<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-06-01" modified="2020-10-07" version="212">
<accession>Q12879</accession>
<accession>O00669</accession>
<accession>Q17RZ6</accession>
<name>NMDE1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Glutamate receptor ionotropic, NMDA 2A</fullName>
<shortName>GluN2A</shortName>
</recommendedName>
<alternativeName>
<fullName>Glutamate [NMDA] receptor subunit epsilon-1</fullName>
</alternativeName>
<alternativeName>
<fullName>N-methyl D-aspartate receptor subtype 2A</fullName>
<shortName evidence="40">NMDAR2A</shortName>
<shortName>NR2A</shortName>
<shortName evidence="39">hNR2A</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">GRIN2A</name>
<name type="synonym">NMDAR2A</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1994" name="Biochim. Biophys. Acta" volume="1223" first="155" last="159">
<title>Human N-methyl-D-aspartate receptor modulatory subunit hNR2A: cloning and sequencing of the cDNA and primary structure of the protein.</title>
<authorList>
<person name="Foldes R.L."/>
<person name="Adams S.L."/>
<person name="Fantaske R.P."/>
<person name="Kamboj R.K."/>
</authorList>
<dbReference type="PubMed" id="8061049"/>
<dbReference type="DOI" id="10.1016/0167-4889(94)90086-8"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>VARIANT GLU-270</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="J. Pharmacol. Exp. Ther." volume="278" first="808" last="816">
<title>Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.</title>
<authorList>
<person name="Hess S.D."/>
<person name="Daggett L.P."/>
<person name="Crona J."/>
<person name="Deal C."/>
<person name="Lu C.-C."/>
<person name="Urrutia A."/>
<person name="Chavez-Noriega L."/>
<person name="Ellis S.B."/>
<person name="Johnson E.C."/>
<person name="Velicelebi G."/>
</authorList>
<dbReference type="PubMed" id="8768735"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nature" volume="432" first="988" last="994">
<title>The sequence and analysis of duplication-rich human chromosome 16.</title>
<authorList>
<person name="Martin J."/>
<person name="Han C."/>
<person name="Gordon L.A."/>
<person name="Terry A."/>
<person name="Prabhakar S."/>
<person name="She X."/>
<person name="Xie G."/>
<person name="Hellsten U."/>
<person name="Chan Y.M."/>
<person name="Altherr M."/>
<person name="Couronne O."/>
<person name="Aerts A."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Blumer H."/>
<person name="Branscomb E."/>
<person name="Brown N.C."/>
<person name="Bruno W.J."/>
<person name="Buckingham J.M."/>
<person name="Callen D.F."/>
<person name="Campbell C.S."/>
<person name="Campbell M.L."/>
<person name="Campbell E.W."/>
<person name="Caoile C."/>
<person name="Challacombe J.F."/>
<person name="Chasteen L.A."/>
<person name="Chertkov O."/>
<person name="Chi H.C."/>
<person name="Christensen M."/>
<person name="Clark L.M."/>
<person name="Cohn J.D."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Dickson M."/>
<person name="Dimitrijevic-Bussod M."/>
<person name="Escobar J."/>
<person name="Fawcett J.J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Goodstein D."/>
<person name="Goodwin L.A."/>
<person name="Grady D.L."/>
<person name="Grigoriev I."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Hildebrand C.E."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Jewett P.B."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Krawczyk M.-C."/>
<person name="Leyba T."/>
<person name="Longmire J.L."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Ludeman T."/>
<person name="Manohar C.F."/>
<person name="Mark G.A."/>
<person name="McMurray K.L."/>
<person name="Meincke L.J."/>
<person name="Morgan J."/>
<person name="Moyzis R.K."/>
<person name="Mundt M.O."/>
<person name="Munk A.C."/>
<person name="Nandkeshwar R.D."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Predki P."/>
<person name="Parson-Quintana B."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Ricke D.O."/>
<person name="Robinson D.L."/>
<person name="Rodriguez A."/>
<person name="Salamov A."/>
<person name="Saunders E.H."/>
<person name="Scott D."/>
<person name="Shough T."/>
<person name="Stallings R.L."/>
<person name="Stalvey M."/>
<person name="Sutherland R.D."/>
<person name="Tapia R."/>
<person name="Tesmer J.G."/>
<person name="Thayer N."/>
<person name="Thompson L.S."/>
<person name="Tice H."/>
<person name="Torney D.C."/>
<person name="Tran-Gyamfi M."/>
<person name="Tsai M."/>
<person name="Ulanovsky L.E."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="White P.S."/>
<person name="Williams A.L."/>
<person name="Wills P.L."/>
<person name="Wu J.-R."/>
<person name="Wu K."/>
<person name="Yang J."/>
<person name="DeJong P."/>
<person name="Bruce D."/>
<person name="Doggett N.A."/>
<person name="Deaven L."/>
<person name="Schmutz J."/>
<person name="Grimwood J."/>
<person name="Richardson P."/>
<person name="Rokhsar D.S."/>
<person name="Eichler E.E."/>
<person name="Gilna P."/>
<person name="Lucas S.M."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Pennacchio L.A."/>
</authorList>
<dbReference type="PubMed" id="15616553"/>
<dbReference type="DOI" id="10.1038/nature03187"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5" evidence="6 7 9">
<citation type="journal article" date="2016" name="J. Med. Chem." volume="59" first="2760" last="2779">
<title>Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.</title>
<authorList>
<person name="Volgraf M."/>
<person name="Sellers B.D."/>
<person name="Jiang Y."/>
<person name="Wu G."/>
<person name="Ly C.Q."/>
<person name="Villemure E."/>
<person name="Pastor R.M."/>
<person name="Yuen P.W."/>
<person name="Lu A."/>
<person name="Luo X."/>
<person name="Liu M."/>
<person name="Zhang S."/>
<person name="Sun L."/>
<person name="Fu Y."/>
<person name="Lupardus P.J."/>
<person name="Wallweber H.J."/>
<person name="Liederer B.M."/>
<person name="Deshmukh G."/>
<person name="Plise E."/>
<person name="Tay S."/>
<person name="Reynen P."/>
<person name="Herrington J."/>
<person name="Gustafson A."/>
<person name="Liu Y."/>
<person name="Dirksen A."/>
<person name="Dietz M.G."/>
<person name="Liu Y."/>
<person name="Wang T.M."/>
<person name="Hanson J.E."/>
<person name="Hackos D."/>
<person name="Scearce-Levie K."/>
<person name="Schwarz J.B."/>
</authorList>
<dbReference type="PubMed" id="26919761"/>
<dbReference type="DOI" id="10.1021/acs.jmedchem.5b02010"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.12 ANGSTROMS) OF 401-539 AND 566-800 IN COMPLEX WITH GLUTAMATE AND GRIN1</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="6" evidence="2 3 4 5 8">
<citation type="journal article" date="2016" name="Neuron" volume="89" first="983" last="999">
<title>Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function.</title>
<authorList>
<person name="Hackos D.H."/>
<person name="Lupardus P.J."/>
<person name="Grand T."/>
<person name="Chen Y."/>
<person name="Wang T.M."/>
<person name="Reynen P."/>
<person name="Gustafson A."/>
<person name="Wallweber H.J."/>
<person name="Volgraf M."/>
<person name="Sellers B.D."/>
<person name="Schwarz J.B."/>
<person name="Paoletti P."/>
<person name="Sheng M."/>
<person name="Zhou Q."/>
<person name="Hanson J.E."/>
</authorList>
<dbReference type="PubMed" id="26875626"/>
<dbReference type="DOI" id="10.1016/j.neuron.2016.01.016"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.81 ANGSTROMS) OF 401-539 AND 566-800 IN COMPLEX WITH GLUTAMATE AND GRIN1</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="7" evidence="10 11">
<citation type="journal article" date="2017" name="ACS Med. Chem. Lett." volume="8" first="84" last="89">
<title>GluN2A-Selective Pyridopyrimidinone Series of NMDAR Positive Allosteric Modulators with an Improved in Vivo Profile.</title>
<authorList>
<person name="Villemure E."/>
<person name="Volgraf M."/>
<person name="Jiang Y."/>
<person name="Wu G."/>
<person name="Ly C.Q."/>
<person name="Yuen P.W."/>
<person name="Lu A."/>
<person name="Luo X."/>
<person name="Liu M."/>
<person name="Zhang S."/>
<person name="Lupardus P.J."/>
<person name="Wallweber H.J."/>
<person name="Liederer B.M."/>
<person name="Deshmukh G."/>
<person name="Plise E."/>
<person name="Tay S."/>
<person name="Wang T.M."/>
<person name="Hanson J.E."/>
<person name="Hackos D.H."/>
<person name="Scearce-Levie K."/>
<person name="Schwarz J.B."/>
<person name="Sellers B.D."/>
</authorList>
<dbReference type="PubMed" id="28105280"/>
<dbReference type="DOI" id="10.1021/acsmedchemlett.6b00388"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 401-539 AND 566-800 IN COMPLEX WITH GRIN1 AND GLUTAMATE</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>FUNCTION</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2010" name="Nat. Genet." volume="42" first="1021" last="1026">
<title>Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.</title>
<authorList>
<person name="Endele S."/>
<person name="Rosenberger G."/>
<person name="Geider K."/>
<person name="Popp B."/>
<person name="Tamer C."/>
<person name="Stefanova I."/>
<person name="Milh M."/>
<person name="Kortum F."/>
<person name="Fritsch A."/>
<person name="Pientka F.K."/>
<person name="Hellenbroich Y."/>
<person name="Kalscheuer V.M."/>
<person name="Kohlhase J."/>
<person name="Moog U."/>
<person name="Rappold G."/>
<person name="Rauch A."/>
<person name="Ropers H.H."/>
<person name="von Spiczak S."/>
<person name="Tonnies H."/>
<person name="Villeneuve N."/>
<person name="Villard L."/>
<person name="Zabel B."/>
<person name="Zenker M."/>
<person name="Laube B."/>
<person name="Reis A."/>
<person name="Wieczorek D."/>
<person name="Van Maldergem L."/>
<person name="Kutsche K."/>
</authorList>
<dbReference type="PubMed" id="20890276"/>
<dbReference type="DOI" id="10.1038/ng.677"/>
</citation>
<scope>CHROMOSOMAL TRANSLOCATION</scope>
<scope>VARIANT FESD LYS-615</scope>
<scope>CHARACTERIZATION OF VARIANT FESD LYS-615</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2011" name="Nat. Genet." volume="43" first="442" last="446">
<title>Exome sequencing identifies GRIN2A as frequently mutated in melanoma.</title>
<authorList>
<person name="Wei X."/>
<person name="Walia V."/>
<person name="Lin J.C."/>
<person name="Teer J.K."/>
<person name="Prickett T.D."/>
<person name="Gartner J."/>
<person name="Davis S."/>
<person name="Stemke-Hale K."/>
<person name="Davies M.A."/>
<person name="Gershenwald J.E."/>
<person name="Robinson W."/>
<person name="Robinson S."/>
<person name="Rosenberg S.A."/>
<person name="Samuels Y."/>
</authorList>
<dbReference type="PubMed" id="21499247"/>
<dbReference type="DOI" id="10.1038/ng.810"/>
</citation>
<scope>PROBABLE INVOLVEMENT IN MELANOMA</scope>
<scope>VARIANTS LEU-57; ILE-183; ASN-252; PHE-278; LYS-371; LYS-373; GLU-449; SER-459; ARG-595; PHE-598; ILE-653; GLU-712; TRP-740; GLU-889; LYS-920; PHE-929; LYS-962; LYS-1073; LEU-1074; ASN-1153; LYS-1175; GLY-1276; LYS-1285; TRP-1318; LEU-1366; ASN-1421; LEU-1425; LYS-1426 AND CYS-1462</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2011" name="Transl. Psychiatry" volume="1" first="E55" last="E55">
<title>Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia.</title>
<authorList>
<consortium name="S2D team"/>
<person name="Tarabeux J."/>
<person name="Kebir O."/>
<person name="Gauthier J."/>
<person name="Hamdan F.F."/>
<person name="Xiong L."/>
<person name="Piton A."/>
<person name="Spiegelman D."/>
<person name="Henrion E."/>
<person name="Millet B."/>
<person name="Fathalli F."/>
<person name="Joober R."/>
<person name="Rapoport J.L."/>
<person name="DeLisi L.E."/>
<person name="Fombonne E."/>
<person name="Mottron L."/>
<person name="Forget-Dubois N."/>
<person name="Boivin M."/>
<person name="Michaud J.L."/>
<person name="Drapeau P."/>
<person name="Lafreniere R.G."/>
<person name="Rouleau G.A."/>
<person name="Krebs M.O."/>
</authorList>
<dbReference type="PubMed" id="22833210"/>
<dbReference type="DOI" id="10.1038/tp.2011.52"/>
</citation>
<scope>VARIANTS ILE-143; ASN-189; SER-336; MET-452; SER-576; MET-852; VAL-922; ASN-937; THR-968; MET-998; ALA-1064; SER-1229 AND GLY-1276</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2012" name="N. Engl. J. Med." volume="367" first="1921" last="1929">
<title>Diagnostic exome sequencing in persons with severe intellectual disability.</title>
<authorList>
<person name="de Ligt J."/>
<person name="Willemsen M.H."/>
<person name="van Bon B.W."/>
<person name="Kleefstra T."/>
<person name="Yntema H.G."/>
<person name="Kroes T."/>
<person name="Vulto-van Silfhout A.T."/>
<person name="Koolen D.A."/>
<person name="de Vries P."/>
<person name="Gilissen C."/>
<person name="del Rosario M."/>
<person name="Hoischen A."/>
<person name="Scheffer H."/>
<person name="de Vries B.B."/>
<person name="Brunner H.G."/>
<person name="Veltman J.A."/>
<person name="Vissers L.E."/>
</authorList>
<dbReference type="PubMed" id="23033978"/>
<dbReference type="DOI" id="10.1056/nejmoa1206524"/>
</citation>
<scope>VARIANTS FESD ARG-552 AND VAL-649</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2013" name="Nat. Genet." volume="45" first="1061" last="1066">
<title>GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction.</title>
<authorList>
<person name="Lesca G."/>
<person name="Rudolf G."/>
<person name="Bruneau N."/>
<person name="Lozovaya N."/>
<person name="Labalme A."/>
<person name="Boutry-Kryza N."/>
<person name="Salmi M."/>
<person name="Tsintsadze T."/>
<person name="Addis L."/>
<person name="Motte J."/>
<person name="Wright S."/>
<person name="Tsintsadze V."/>
<person name="Michel A."/>
<person name="Doummar D."/>
<person name="Lascelles K."/>
<person name="Strug L."/>
<person name="Waters P."/>
<person name="de Bellescize J."/>
<person name="Vrielynck P."/>
<person name="de Saint Martin A."/>
<person name="Ville D."/>
<person name="Ryvlin P."/>
<person name="Arzimanoglou A."/>
<person name="Hirsch E."/>
<person name="Vincent A."/>
<person name="Pal D."/>
<person name="Burnashev N."/>
<person name="Sanlaville D."/>
<person name="Szepetowski P."/>
</authorList>
<dbReference type="PubMed" id="23933820"/>
<dbReference type="DOI" id="10.1038/ng.2726"/>
</citation>
<scope>VARIANTS FESD SER-184; SER-295; ARG-483; TRP-504; HIS-518; THR-548; VAL-652; ASN-669; THR-694; THR-716; ASN-731; ASN-933 AND ASN-1251</scope>
<scope>VARIANT GLY-1276</scope>
<scope>CHARACTERIZATION OF VARIANTS FESD HIS-518 AND VAL-652</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2013" name="Nat. Genet." volume="45" first="1067" last="1072">
<title>Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes.</title>
<authorList>
<person name="Lemke J.R."/>
<person name="Lal D."/>
<person name="Reinthaler E.M."/>
<person name="Steiner I."/>
<person name="Nothnagel M."/>
<person name="Alber M."/>
<person name="Geider K."/>
<person name="Laube B."/>
<person name="Schwake M."/>
<person name="Finsterwalder K."/>
<person name="Franke A."/>
<person name="Schilhabel M."/>
<person name="Jahn J.A."/>
<person name="Muhle H."/>
<person name="Boor R."/>
<person name="Van Paesschen W."/>
<person name="Caraballo R."/>
<person name="Fejerman N."/>
<person name="Weckhuysen S."/>
<person name="De Jonghe P."/>
<person name="Larsen J."/>
<person name="Moller R.S."/>
<person name="Hjalgrim H."/>
<person name="Addis L."/>
<person name="Tang S."/>
<person name="Hughes E."/>
<person name="Pal D.K."/>
<person name="Veri K."/>
<person name="Vaher U."/>
<person name="Talvik T."/>
<person name="Dimova P."/>
<person name="Guerrero Lopez R."/>
<person name="Serratosa J.M."/>
<person name="Linnankivi T."/>
<person name="Lehesjoki A.E."/>
<person name="Ruf S."/>
<person name="Wolff M."/>
<person name="Buerki S."/>
<person name="Wohlrab G."/>
<person name="Kroell J."/>
<person name="Datta A.N."/>
<person name="Fiedler B."/>
<person name="Kurlemann G."/>
<person name="Kluger G."/>
<person name="Hahn A."/>
<person name="Haberlandt D.E."/>
<person name="Kutzer C."/>
<person name="Sperner J."/>
<person name="Becker F."/>
<person name="Weber Y.G."/>
<person name="Feucht M."/>
<person name="Steinbock H."/>
<person name="Neophythou B."/>
<person name="Ronen G.M."/>
<person name="Gruber-Sedlmayr U."/>
<person name="Geldner J."/>
<person name="Harvey R.J."/>
<person name="Hoffmann P."/>
<person name="Herms S."/>
<person name="Altmuller J."/>
<person name="Toliat M.R."/>
<person name="Thiele H."/>
<person name="Nurnberg P."/>
<person name="Wilhelm C."/>
<person name="Stephani U."/>
<person name="Helbig I."/>
<person name="Lerche H."/>
<person name="Zimprich F."/>
<person name="Neubauer B.A."/>
<person name="Biskup S."/>
<person name="von Spiczak S."/>
</authorList>
<dbReference type="PubMed" id="23933819"/>
<dbReference type="DOI" id="10.1038/ng.2728"/>
</citation>
<scope>VARIANTS FESD ARG-79; TYR-231; VAL-243; VAL-290; TRP-370; ARG-436; SER-547 DEL; SER-699; VAL-705; LYS-714; THR-727; LEU-734; GLU-772; THR-814; PHE-904 AND SER-976</scope>
<scope>VARIANT ILE-183</scope>
<scope>CHARACTERIZATION OF VARIANT FESD VAL-243</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2013" name="Nat. Genet." volume="45" first="1073" last="1076">
<title>GRIN2A mutations cause epilepsy-aphasia spectrum disorders.</title>
<authorList>
<person name="Carvill G.L."/>
<person name="Regan B.M."/>
<person name="Yendle S.C."/>
<person name="O'Roak B.J."/>
<person name="Lozovaya N."/>
<person name="Bruneau N."/>
<person name="Burnashev N."/>
<person name="Khan A."/>
<person name="Cook J."/>
<person name="Geraghty E."/>
<person name="Sadleir L.G."/>
<person name="Turner S.J."/>
<person name="Tsai M.H."/>
<person name="Webster R."/>
<person name="Ouvrier R."/>
<person name="Damiano J.A."/>
<person name="Berkovic S.F."/>
<person name="Shendure J."/>
<person name="Hildebrand M.S."/>
<person name="Szepetowski P."/>
<person name="Scheffer I.E."/>
<person name="Mefford H.C."/>
</authorList>
<dbReference type="PubMed" id="23933818"/>
<dbReference type="DOI" id="10.1038/ng.2727"/>
</citation>
<scope>VARIANT FESD MET-531</scope>
<scope>CHARACTERIZATION OF VARIANT FESD MET-531</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2014" name="Front. Oncol." volume="3" first="333" last="333">
<title>Evidence that GRIN2A mutations in melanoma correlate with decreased survival.</title>
<authorList>
<person name="D'mello S.A."/>
<person name="Flanagan J.U."/>
<person name="Green T.N."/>
<person name="Leung E.Y."/>
<person name="Askarian-Amiri M.E."/>
<person name="Joseph W.R."/>
<person name="McCrystal M.R."/>
<person name="Isaacs R.J."/>
<person name="Shaw J.H."/>
<person name="Furneaux C.E."/>
<person name="During M.J."/>
<person name="Finlay G.J."/>
<person name="Baguley B.C."/>
<person name="Kalev-Zylinska M.L."/>
</authorList>
<dbReference type="PubMed" id="24455489"/>
<dbReference type="DOI" id="10.3389/fonc.2013.00333"/>
</citation>
<scope>PROBABLE INVOLVEMENT IN MELANOMA</scope>
<scope>VARIANTS PHE-349; ALA-762; GLU-889; LEU-1132 AND SER-1133</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2014" name="Epilepsia" volume="55" first="E75" last="E79">
<title>Whole-exome sequencing in an individual with severe global developmental delay and intractable epilepsy identifies a novel, de novo GRIN2A mutation.</title>
<authorList>
<consortium name="FORGE Canada Consortium"/>
<person name="Venkateswaran S."/>
<person name="Myers K.A."/>
<person name="Smith A.C."/>
<person name="Beaulieu C.L."/>
<person name="Schwartzentruber J.A."/>
<person name="Majewski J."/>
<person name="Bulman D."/>
<person name="Boycott K.M."/>
<person name="Dyment D.A."/>
</authorList>
<dbReference type="PubMed" id="24903190"/>
<dbReference type="DOI" id="10.1111/epi.12663"/>
</citation>
<scope>VARIANT FESD VAL-817</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2014" name="Nat. Commun." volume="5" first="3251" last="3251">
<title>Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy.</title>
<authorList>
<person name="Yuan H."/>
<person name="Hansen K.B."/>
<person name="Zhang J."/>
<person name="Pierson T.M."/>
<person name="Markello T.C."/>
<person name="Fajardo K.V."/>
<person name="Holloman C.M."/>
<person name="Golas G."/>
<person name="Adams D.R."/>
<person name="Boerkoel C.F."/>
<person name="Gahl W.A."/>
<person name="Traynelis S.F."/>
</authorList>
<dbReference type="PubMed" id="24504326"/>
<dbReference type="DOI" id="10.1038/ncomms4251"/>
</citation>
<scope>VARIANT FESD MET-812</scope>
<scope>CHARACTERIZATION OF VARIANT FESD MET-812</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2015" name="Neuron" volume="88" first="910" last="917">
<title>Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms.</title>
<authorList>
<person name="D'Gama A.M."/>
<person name="Pochareddy S."/>
<person name="Li M."/>
<person name="Jamuar S.S."/>
<person name="Reiff R.E."/>
<person name="Lam A.T."/>
<person name="Sestan N."/>
<person name="Walsh C.A."/>
</authorList>
<dbReference type="PubMed" id="26637798"/>
<dbReference type="DOI" id="10.1016/j.neuron.2015.11.009"/>
</citation>
<scope>VARIANT ASN-884</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2016" name="Am. J. Hum. Genet." volume="99" first="1261" last="1280">
<title>Mechanistic insight into NMDA receptor dysregulation by rare variants in the GluN2A and GluN2B agonist binding domains.</title>
<authorList>
<person name="Swanger S.A."/>
<person name="Chen W."/>
<person name="Wells G."/>
<person name="Burger P.B."/>
<person name="Tankovic A."/>
<person name="Bhattacharya S."/>
<person name="Strong K.L."/>
<person name="Hu C."/>
<person name="Kusumoto H."/>
<person name="Zhang J."/>
<person name="Adams D.R."/>
<person name="Millichap J.J."/>
<person name="Petrovski S."/>
<person name="Traynelis S.F."/>
<person name="Yuan H."/>
</authorList>
<dbReference type="PubMed" id="27839871"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2016.10.002"/>
</citation>
<scope>VARIANTS FESD ALA-506 AND GLY-685</scope>
<scope>CHARACTERIZATION OF VARIANT FESD ARG-436; ARG-483; TRP-504; ALA-506; HIS-518; MET-531; ASN-669; GLY-685; THR-694; SER-699; VAL-705; LYS-714; THR-716; THR-727; ASN-731; LEU-734; GLU-772</scope>
<scope>CHARACTERIZATION OF VARIANT MET-452</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="216" last="225">
<title>Diagnostic targeted resequencing in 349 patients with drug-resistant pediatric epilepsies identifies causative mutations in 30 different genes.</title>
<authorList>
<consortium name="Clinical Study Group"/>
<person name="Parrini E."/>
<person name="Marini C."/>
<person name="Mei D."/>
<person name="Galuppi A."/>
<person name="Cellini E."/>
<person name="Pucatti D."/>
<person name="Chiti L."/>
<person name="Rutigliano D."/>
<person name="Bianchini C."/>
<person name="Virdo S."/>
<person name="De Vita D."/>
<person name="Bigoni S."/>
<person name="Barba C."/>
<person name="Mari F."/>
<person name="Montomoli M."/>
<person name="Pisano T."/>
<person name="Rosati A."/>
<person name="Guerrini R."/>
</authorList>
<dbReference type="PubMed" id="27864847"/>
<dbReference type="DOI" id="10.1002/humu.23149"/>
</citation>
<scope>VARIANTS ASP-380; SER-989 AND GLY-1276</scope>
<scope>VARIANT FESD ASP-716</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2017" name="Mol. Pharmacol." volume="91" first="317" last="330">
<title>Functional evaluation of a de novo GRIN2A mutation identified in a patient with profound global developmental delay and refractory epilepsy.</title>
<authorList>
<person name="Chen W."/>
<person name="Tankovic A."/>
<person name="Burger P.B."/>
<person name="Kusumoto H."/>
<person name="Traynelis S.F."/>
<person name="Yuan H."/>
</authorList>
<dbReference type="PubMed" id="28126851"/>
<dbReference type="DOI" id="10.1124/mol.116.106781"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT FESD VAL-817</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2017" name="PLoS ONE" volume="12" first="E0170818" last="E0170818">
<title>A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.</title>
<authorList>
<person name="Gao K."/>
<person name="Tankovic A."/>
<person name="Zhang Y."/>
<person name="Kusumoto H."/>
<person name="Zhang J."/>
<person name="Chen W."/>
<person name="XiangWei W."/>
<person name="Shaulsky G.H."/>
<person name="Hu C."/>
<person name="Traynelis S.F."/>
<person name="Yuan H."/>
<person name="Jiang Y."/>
</authorList>
<dbReference type="PubMed" id="28182669"/>
<dbReference type="DOI" id="10.1371/journal.pone.0170818"/>
</citation>
<scope>VARIANT FESD ASN-731</scope>
<scope>CHARACTERIZATION OF VARIANT FESD ASN-731</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2017" name="PLoS Genet." volume="13" first="E1006536" last="E1006536">
<title>Molecular mechanism of disease-associated mutations in the pre-M1 helix of NMDA receptors and potential rescue pharmacology.</title>
<authorList>
<person name="Ogden K.K."/>
<person name="Chen W."/>
<person name="Swanger S.A."/>
<person name="McDaniel M.J."/>
<person name="Fan L.Z."/>
<person name="Hu C."/>
<person name="Tankovic A."/>
<person name="Kusumoto H."/>
<person name="Kosobucki G.J."/>
<person name="Schulien A.J."/>
<person name="Su Z."/>
<person name="Pecha J."/>
<person name="Bhattacharya S."/>
<person name="Petrovski S."/>
<person name="Cohen A.E."/>
<person name="Aizenman E."/>
<person name="Traynelis S.F."/>
<person name="Yuan H."/>
</authorList>
<dbReference type="PubMed" id="28095420"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1006536"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS FESD THR-548 AND ARG-552</scope>
<scope>MUTAGENESIS OF PRO-552</scope>
</reference>
<comment type="function">
<text evidence="14 15 28 29 33 37">Component of NMDA receptor complexes that function as heterotetrameric, ligand-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Channel activation requires binding of the neurotransmitter glutamate to the epsilon subunit, glycine binding to the zeta subunit, plus membrane depolarization to eliminate channel inhibition by Mg(2+) (PubMed:8768735, PubMed:26919761, PubMed:26875626, PubMed:28105280). Sensitivity to glutamate and channel kinetics depend on the subunit composition; channels containing GRIN1 and GRIN2A have lower sensitivity to glutamate and faster deactivation kinetics than channels formed by GRIN1 and GRIN2B (PubMed:26919761, PubMed:26875626). Contributes to the slow phase of excitatory postsynaptic current, long-term synaptic potentiation, and learning (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="14 15 28 29 33 37">Heterotetramer. Forms heterotetrameric channels composed of two zeta subunits (GRIN1), and two epsilon subunits (GRIN2A, GRIN2B, GRIN2C or GRIN2D) (in vitro) (PubMed:8768735, PubMed:26919761, PubMed:26875626, PubMed:28105280). Can also form heterotetrameric channels that contain at least one zeta subunit (GRIN1), at least one epsilon subunit, plus GRIN3A or GRIN3B. In vivo, the subunit composition may depend on the expression levels of the different subunits. Found in a complex with GRIN1, GRIN3A and PPP2CB (By similarity). Found in a complex with GRIN1 and GRIN3B (By similarity). Interacts with AIP1 (By similarity). Interacts with HIP1 and NETO1. Interacts with SNX27 (via PDZ domain); the interaction is required for recycling to the plasma membrane when endocytosed and prevent degradation in lysosomes (By similarity). Interacts with PDZ domains of PATJ and DLG4. Interacts with LRFN2 (By similarity). Interacts with RPH3A and DLG4; this ternary complex regulates NMDA receptor composition at postsynaptic membranes (By similarity). Interacts with SORCS2 (By similarity). Interacts with ARC; preventing ARC oligomerization (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7249937">
<id>Q12879</id>
</interactant>
<interactant intactId="EBI-80389">
<id>P78352</id>
<label>DLG4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7249937">
<id>Q12879</id>
</interactant>
<interactant intactId="EBI-1046087">
<id>Q07954</id>
<label>LRP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7249937">
<id>Q12879</id>
</interactant>
<interactant intactId="EBI-349596">
<id>Q62936</id>
<label>Dlg3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7249937">
<id>Q12879</id>
</interactant>
<interactant intactId="EBI-375655">
<id>P31016</id>
<label>Dlg4</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="15">Cell projection</location>
<location evidence="15">Dendritic spine</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="28 29 33 37">Cell membrane</location>
<topology evidence="41">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Cell junction</location>
<location evidence="14">Synapse</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Cell junction</location>
<location evidence="15">Synapse</location>
<location evidence="15">Postsynaptic cell membrane</location>
<topology evidence="41">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Cytoplasmic vesicle membrane</location>
</subcellularLocation>
<text evidence="14">Expression at the dendrite cell membrane and at synapses is regulated by SORCS2 and the retromer complex.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q12879-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q12879-2</id>
<name>2</name>
<sequence type="described" ref="VSP_044300"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="15">Contains an N-terminal domain, a ligand-binding domain and a transmembrane domain. Agonist binding to the extracellular ligand-binding domains triggers channel gating.</text>
</comment>
<comment type="domain">
<text evidence="13">A hydrophobic region that gives rise to the prediction of a transmembrane span does not cross the membrane, but is part of a discontinuously helical region that dips into the membrane and is probably part of the pore and of the selectivity filter.</text>
</comment>
<comment type="disease" evidence="17 20 21 22 23 25 26 30 31 32 34 35">
<disease id="DI-03169">
<name>Epilepsy, focal, with speech disorder and with or without mental retardation</name>
<acronym>FESD</acronym>
<description>A highly variable neurologic disorder with features ranging from severe early-onset seizures associated with delayed psychomotor development, persistent speech difficulties, and mental retardation to a more benign entity characterized by childhood onset of mild or asymptomatic seizures associated with transient speech difficulties followed by remission of seizures in adolescence and normal psychomotor development. The disorder encompasses several clinical entities, including Landau-Kleffner syndrome, epileptic encephalopathy with continuous spike and wave during slow-wave sleep, autosomal dominant rolandic epilepsy, mental retardation and speech dyspraxia, and benign epilepsy with centrotemporal spikes.</description>
<dbReference type="MIM" id="245570"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text>A chromosomal aberration involving GRIN2A has been found in a family with epilepsy and neurodevelopmental defects. Translocation t(16;17)(p13.2;q11.2).</text>
</comment>
<comment type="disease">
<text evidence="18 24">GRIN2A somatic mutations have been frequently found in cutaneous malignant melanoma, suggesting that the glutamate signaling pathway may play a role in the pathogenesis of melanoma.</text>
</comment>
<comment type="similarity">
<text evidence="41">Belongs to the glutamate-gated ion channel (TC 1.A.10.1) family. NR2A/GRIN2A subfamily.</text>
</comment>
<dbReference type="EMBL" id="U09002">
<property type="protein sequence ID" value="AAB60343.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U90277">
<property type="protein sequence ID" value="AAB49992.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC006531">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007218">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC022168">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC026423">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC133565">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC117131">
<property type="protein sequence ID" value="AAI17132.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC143273">
<property type="protein sequence ID" value="AAI43274.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS10539.1">
<molecule id="Q12879-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS45407.1">
<molecule id="Q12879-2"/>
</dbReference>
<dbReference type="PIR" id="S47555">
<property type="entry name" value="S47555"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000824.1">
<molecule id="Q12879-1"/>
<property type="nucleotide sequence ID" value="NM_000833.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001127879.1">
<molecule id="Q12879-1"/>
<property type="nucleotide sequence ID" value="NM_001134407.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001127880.1">
<molecule id="Q12879-2"/>
<property type="nucleotide sequence ID" value="NM_001134408.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011520763.1">
<molecule id="Q12879-2"/>
<property type="nucleotide sequence ID" value="XM_011522461.2"/>
</dbReference>
<dbReference type="PDB" id="3NFL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.91"/>
<property type="chains" value="E/F/G/H=1449-1464"/>
</dbReference>
<dbReference type="PDB" id="5H8F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.81"/>
<property type="chains" value="A=401-539, A=661-802"/>
</dbReference>
<dbReference type="PDB" id="5H8H">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.23"/>
<property type="chains" value="A=401-539, A=661-802"/>
</dbReference>
<dbReference type="PDB" id="5H8N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=401-539, A=661-802"/>
</dbReference>
<dbReference type="PDB" id="5H8Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=401-539, A=661-802"/>
</dbReference>
<dbReference type="PDB" id="5I2K">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.86"/>
<property type="chains" value="A=401-539, A=661-802"/>
</dbReference>
<dbReference type="PDB" id="5I2N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.12"/>
<property type="chains" value="A=401-539, A=661-802"/>
</dbReference>
<dbReference type="PDB" id="5KCJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.09"/>
<property type="chains" value="A=401-539, A=661-802"/>
</dbReference>
<dbReference type="PDB" id="5KDT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.44"/>
<property type="chains" value="A=401-539, A=661-802"/>
</dbReference>
<dbReference type="PDB" id="5TP9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=401-539, A=661-802"/>
</dbReference>
<dbReference type="PDB" id="5TPA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.48"/>
<property type="chains" value="A=401-539, A=661-802"/>
</dbReference>
<dbReference type="PDB" id="6IRA">
<property type="method" value="EM"/>
<property type="resolution" value="4.50"/>
<property type="chains" value="B/D=1-842"/>
</dbReference>
<dbReference type="PDB" id="6IRF">
<property type="method" value="EM"/>
<property type="resolution" value="5.10"/>
<property type="chains" value="B/D=1-841"/>
</dbReference>
<dbReference type="PDB" id="6IRG">
<property type="method" value="EM"/>
<property type="resolution" value="5.50"/>
<property type="chains" value="B/D=1-841"/>
</dbReference>
<dbReference type="PDB" id="6IRH">
<property type="method" value="EM"/>
<property type="resolution" value="7.80"/>
<property type="chains" value="B/D=1-841"/>
</dbReference>
<dbReference type="PDBsum" id="3NFL"/>
<dbReference type="PDBsum" id="5H8F"/>
<dbReference type="PDBsum" id="5H8H"/>
<dbReference type="PDBsum" id="5H8N"/>
<dbReference type="PDBsum" id="5H8Q"/>
<dbReference type="PDBsum" id="5I2K"/>
<dbReference type="PDBsum" id="5I2N"/>
<dbReference type="PDBsum" id="5KCJ"/>
<dbReference type="PDBsum" id="5KDT"/>
<dbReference type="PDBsum" id="5TP9"/>
<dbReference type="PDBsum" id="5TPA"/>
<dbReference type="PDBsum" id="6IRA"/>
<dbReference type="PDBsum" id="6IRF"/>
<dbReference type="PDBsum" id="6IRG"/>
<dbReference type="PDBsum" id="6IRH"/>
<dbReference type="SMR" id="Q12879"/>
<dbReference type="BioGRID" id="109160">
<property type="interactions" value="54"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2202">
<property type="entry name" value="NMDA receptor complex, GluN1-GluN2A"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-294">
<property type="entry name" value="NMDA receptor complex, GluN1-GluN2A-GluN2B"/>
</dbReference>
<dbReference type="CORUM" id="Q12879"/>
<dbReference type="DIP" id="DIP-40798N"/>
<dbReference type="IntAct" id="Q12879">
<property type="interactions" value="6"/>
</dbReference>
<dbReference type="MINT" id="Q12879"/>
<dbReference type="STRING" id="9606.ENSP00000379818"/>
<dbReference type="BindingDB" id="Q12879"/>
<dbReference type="ChEMBL" id="CHEMBL1972"/>
<dbReference type="DrugBank" id="DB00659">
<property type="generic name" value="Acamprosate"/>
</dbReference>
<dbReference type="DrugBank" id="DB06151">
<property type="generic name" value="Acetylcysteine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01238">
<property type="generic name" value="Aripiprazole"/>
</dbReference>
<dbReference type="DrugBank" id="DB00289">
<property type="generic name" value="Atomoxetine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00843">
<property type="generic name" value="Donepezil"/>
</dbReference>
<dbReference type="DrugBank" id="DB11823">
<property type="generic name" value="Esketamine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00949">
<property type="generic name" value="Felbamate"/>
</dbReference>
<dbReference type="DrugBank" id="DB13146">
<property type="generic name" value="Fluciclovine (18F)"/>
</dbReference>
<dbReference type="DrugBank" id="DB06741">
<property type="generic name" value="Gavestinel"/>
</dbReference>
<dbReference type="DrugBank" id="DB00142">
<property type="generic name" value="Glutamic acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB00145">
<property type="generic name" value="Glycine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00874">
<property type="generic name" value="Guaifenesin"/>
</dbReference>
<dbReference type="DrugBank" id="DB01159">
<property type="generic name" value="Halothane"/>
</dbReference>
<dbReference type="DrugBank" id="DB06738">
<property type="generic name" value="Ketobemidone"/>
</dbReference>
<dbReference type="DrugBank" id="DB09409">
<property type="generic name" value="Magnesium acetate tetrahydrate"/>
</dbReference>
<dbReference type="DrugBank" id="DB09481">
<property type="generic name" value="Magnesium carbonate"/>
</dbReference>
<dbReference type="DrugBank" id="DB01043">
<property type="generic name" value="Memantine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00454">
<property type="generic name" value="Meperidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00333">
<property type="generic name" value="Methadone"/>
</dbReference>
<dbReference type="DrugBank" id="DB04896">
<property type="generic name" value="Milnacipran"/>
</dbReference>
<dbReference type="DrugBank" id="DB00312">
<property type="generic name" value="Pentobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB01174">
<property type="generic name" value="Phenobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB01708">
<property type="generic name" value="Prasterone"/>
</dbReference>
<dbReference type="DrugBank" id="DB00418">
<property type="generic name" value="Secobarbital"/>
</dbReference>
<dbReference type="DrugBank" id="DB01520">
<property type="generic name" value="Tenocyclidine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00193">
<property type="generic name" value="Tramadol"/>
</dbReference>
<dbReference type="DrugCentral" id="Q12879"/>
<dbReference type="GuidetoPHARMACOLOGY" id="456"/>
<dbReference type="TCDB" id="1.A.10.1.20">
<property type="family name" value="the glutamate-gated ion channel (gic) family of neurotransmitter receptors"/>
</dbReference>
<dbReference type="GlyGen" id="Q12879">
<property type="glycosylation" value="6 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="Q12879"/>
<dbReference type="PhosphoSitePlus" id="Q12879"/>
<dbReference type="BioMuta" id="GRIN2A"/>
<dbReference type="DMDM" id="14285603"/>
<dbReference type="MassIVE" id="Q12879"/>
<dbReference type="PaxDb" id="Q12879"/>
<dbReference type="PeptideAtlas" id="Q12879"/>
<dbReference type="PRIDE" id="Q12879"/>
<dbReference type="ProteomicsDB" id="58998">
<molecule id="Q12879-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="61175"/>
<dbReference type="Antibodypedia" id="1402">
<property type="antibodies" value="751 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="2903"/>
<dbReference type="Ensembl" id="ENST00000330684">
<molecule id="Q12879-1"/>
<property type="protein sequence ID" value="ENSP00000332549"/>
<property type="gene ID" value="ENSG00000183454"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000396573">
<molecule id="Q12879-1"/>
<property type="protein sequence ID" value="ENSP00000379818"/>
<property type="gene ID" value="ENSG00000183454"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000562109">
<molecule id="Q12879-2"/>
<property type="protein sequence ID" value="ENSP00000454998"/>
<property type="gene ID" value="ENSG00000183454"/>
</dbReference>
<dbReference type="GeneID" id="2903"/>
<dbReference type="KEGG" id="hsa:2903"/>
<dbReference type="UCSC" id="uc002czr.5">
<molecule id="Q12879-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="2903"/>
<dbReference type="DisGeNET" id="2903"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000183454.14"/>
<dbReference type="GeneCards" id="GRIN2A"/>
<dbReference type="GeneReviews" id="GRIN2A"/>
<dbReference type="HGNC" id="HGNC:4585">
<property type="gene designation" value="GRIN2A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000183454">
<property type="expression patterns" value="Tissue enriched (brain)"/>
</dbReference>
<dbReference type="MalaCards" id="GRIN2A"/>
<dbReference type="MIM" id="138253">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="245570">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q12879"/>
<dbReference type="OpenTargets" id="ENSG00000183454"/>
<dbReference type="Orphanet" id="725">
<property type="disease" value="Continuous spikes and waves during sleep"/>
</dbReference>
<dbReference type="Orphanet" id="289266">
<property type="disease" value="Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation"/>
</dbReference>
<dbReference type="Orphanet" id="98818">
<property type="disease" value="Landau-Kleffner syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="1945">
<property type="disease" value="Rolandic epilepsy"/>
</dbReference>
<dbReference type="Orphanet" id="163721">
<property type="disease" value="Rolandic epilepsy-speech dyspraxia syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28979"/>
<dbReference type="eggNOG" id="KOG1053">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156222"/>
<dbReference type="HOGENOM" id="CLU_002598_0_0_1"/>
<dbReference type="InParanoid" id="Q12879"/>
<dbReference type="KO" id="K05209"/>
<dbReference type="OMA" id="PKYPRDC"/>
<dbReference type="OrthoDB" id="188544at2759"/>
<dbReference type="PhylomeDB" id="Q12879"/>
<dbReference type="TreeFam" id="TF314731"/>
<dbReference type="PathwayCommons" id="Q12879"/>
<dbReference type="Reactome" id="R-HSA-438066">
<property type="pathway name" value="Unblocking of NMDA receptors, glutamate binding and activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6794361">
<property type="pathway name" value="Neurexins and neuroligins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8849932">
<property type="pathway name" value="Synaptic adhesion-like molecules"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9022699">
<property type="pathway name" value="MECP2 regulates neuronal receptors and channels"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9609736">
<property type="pathway name" value="Assembly and cell surface presentation of NMDA receptors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9617324">
<property type="pathway name" value="Negative regulation of NMDA receptor-mediated neuronal transmission"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9620244">
<property type="pathway name" value="Long-term potentiation"/>
</dbReference>
<dbReference type="SignaLink" id="Q12879"/>
<dbReference type="SIGNOR" id="Q12879"/>
<dbReference type="BioGRID-ORCS" id="2903">
<property type="hits" value="4 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="GRIN2A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q12879"/>
<dbReference type="GeneWiki" id="GRIN2A"/>
<dbReference type="GenomeRNAi" id="2903"/>
<dbReference type="Pharos" id="Q12879">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:Q12879"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 16"/>
</dbReference>
<dbReference type="RNAct" id="Q12879">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000183454">
<property type="expression patterns" value="Expressed in primary visual cortex and 157 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q12879">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q12879">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030659">
<property type="term" value="C:cytoplasmic vesicle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0043197">
<property type="term" value="C:dendritic spine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0099061">
<property type="term" value="C:integral component of postsynaptic density membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0017146">
<property type="term" value="C:NMDA selective glutamate receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014069">
<property type="term" value="C:postsynaptic density"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098839">
<property type="term" value="C:postsynaptic density membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042734">
<property type="term" value="C:presynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097060">
<property type="term" value="C:synaptic membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008021">
<property type="term" value="C:synaptic vesicle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001540">
<property type="term" value="F:amyloid-beta binding"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0022849">
<property type="term" value="F:glutamate-gated calcium ion channel activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015276">
<property type="term" value="F:ligand-gated ion channel activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0004972">
<property type="term" value="F:NMDA glutamate receptor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0038023">
<property type="term" value="F:signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097202">
<property type="term" value="P:activation of cysteine-type endopeptidase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097553">
<property type="term" value="P:calcium ion transmembrane import into cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007268">
<property type="term" value="P:chemical synaptic transmission"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0033058">
<property type="term" value="P:directional locomotion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042417">
<property type="term" value="P:dopamine metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0098976">
<property type="term" value="P:excitatory chemical synaptic transmission"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060079">
<property type="term" value="P:excitatory postsynaptic potential"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007215">
<property type="term" value="P:glutamate receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007611">
<property type="term" value="P:learning or memory"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0060291">
<property type="term" value="P:long-term synaptic potentiation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007613">
<property type="term" value="P:memory"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042177">
<property type="term" value="P:negative regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0022008">
<property type="term" value="P:neurogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903539">
<property type="term" value="P:protein localization to postsynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2000310">
<property type="term" value="P:regulation of NMDA receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048167">
<property type="term" value="P:regulation of synaptic plasticity"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001975">
<property type="term" value="P:response to amphetamine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045471">
<property type="term" value="P:response to ethanol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009611">
<property type="term" value="P:response to wounding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019233">
<property type="term" value="P:sensory perception of pain"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042428">
<property type="term" value="P:serotonin metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030431">
<property type="term" value="P:sleep"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001964">
<property type="term" value="P:startle response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008542">
<property type="term" value="P:visual learning"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="IDEAL" id="IID00664"/>
<dbReference type="InterPro" id="IPR001828">
<property type="entry name" value="ANF_lig-bd_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR019594">
<property type="entry name" value="Glu/Gly-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001508">
<property type="entry name" value="Iono_rcpt_met"/>
</dbReference>
<dbReference type="InterPro" id="IPR001320">
<property type="entry name" value="Iontro_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR018884">
<property type="entry name" value="NMDAR2_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR028082">
<property type="entry name" value="Peripla_BP_I"/>
</dbReference>
<dbReference type="Pfam" id="PF01094">
<property type="entry name" value="ANF_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00060">
<property type="entry name" value="Lig_chan"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF10613">
<property type="entry name" value="Lig_chan-Glu_bd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF10565">
<property type="entry name" value="NMDAR2_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00177">
<property type="entry name" value="NMDARECEPTOR"/>
</dbReference>
<dbReference type="SMART" id="SM00918">
<property type="entry name" value="Lig_chan-Glu_bd"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00079">
<property type="entry name" value="PBPe"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF53822">
<property type="entry name" value="SSF53822"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0106">Calcium</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0968">Cytoplasmic vesicle</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0407">Ion channel</keyword>
<keyword id="KW-0406">Ion transport</keyword>
<keyword id="KW-1071">Ligand-gated ion channel</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0628">Postsynaptic cell membrane</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="signal peptide" evidence="16">
<location>
<begin position="1"/>
<end position="22"/>
</location>
</feature>
<feature type="chain" description="Glutamate receptor ionotropic, NMDA 2A" id="PRO_0000011573">
<location>
<begin position="23"/>
<end position="1464"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="13">
<location>
<begin position="23"/>
<end position="555"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="13">
<location>
<begin position="556"/>
<end position="576"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="13">
<location>
<begin position="577"/>
<end position="600"/>
</location>
</feature>
<feature type="intramembrane region" description="Discontinuously helical" evidence="13">
<location>
<begin position="601"/>
<end position="620"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="13">
<location>
<begin position="621"/>
<end position="625"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="13">
<location>
<begin position="626"/>
<end position="645"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="13">
<location>
<begin position="646"/>
<end position="816"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="13">
<location>
<begin position="817"/>
<end position="837"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="13">
<location>
<begin position="838"/>
<end position="1464"/>
</location>
</feature>
<feature type="region of interest" description="Glutamate binding" evidence="2 3 4 5 6 7 8 9 10 11 28 29 33">
<location>
<begin position="511"/>
<end position="513"/>
</location>
</feature>
<feature type="region of interest" description="Pore-forming" evidence="13">
<location>
<begin position="599"/>
<end position="620"/>
</location>
</feature>
<feature type="region of interest" description="Glutamate binding" evidence="15">
<location>
<begin position="689"/>
<end position="690"/>
</location>
</feature>
<feature type="region of interest" description="Glutamate binding" evidence="15">
<location>
<begin position="730"/>
<end position="731"/>
</location>
</feature>
<feature type="short sequence motif" description="PDZ-binding" evidence="41">
<location>
<begin position="1462"/>
<end position="1464"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; via tele nitrogen" evidence="15">
<location>
<position position="44"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; via tele nitrogen" evidence="15">
<location>
<position position="128"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="15">
<location>
<position position="266"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="15">
<location>
<position position="282"/>
</location>
</feature>
<feature type="binding site" description="Glutamate" evidence="2 3 4 5 6 7 8 9 10 11 28 29 33">
<location>
<position position="518"/>
</location>
</feature>
<feature type="site" description="Functional determinant of NMDA receptors" evidence="12">
<location>
<position position="614"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="882"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="890"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="929"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="1025"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="1059"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="1062"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="1198"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15">
<location>
<position position="1291"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="75"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="340"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="380"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="443"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="444"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="541"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="16">
<location>
<position position="687"/>
</location>
</feature>
<feature type="disulfide bond" evidence="15">
<location>
<begin position="87"/>
<end position="320"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 5 6 7 8 9 10 11 28 29 33">
<location>
<begin position="429"/>
<end position="455"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2 3 4 5 6 7 8 9 10 11 28 29 33">
<location>
<begin position="436"/>
<end position="456"/>
</location>
</feature>
<feature type="disulfide bond" evidence="15">
<location>
<begin position="745"/>
<end position="800"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_044300" evidence="38">
<original>NPATGEQVYQQDWAQNNALQLQKNKLRISRQHSYDNIVDKPRELDLSRPSRSISLKDRERLLEGNFYGSLFSVPSSKLSGKKSSLFPQGLEDSKRSKSLLPDHTSDNPFLHSHRDDQRLVIGRCPSDPYKHSLPSQAVNDSYLRSSLRSTASYCSRDSRGHNDVYISEHVMPYAANKNNMYSTPRVLNSCSNRRVYKKMPSIESDV</original>
<variation>MTNAWLLGDAPRTLTNTRCHPRR</variation>
<location>
<begin position="1259"/>
<end position="1464"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation." id="VAR_067725" evidence="18">
<original>P</original>
<variation>L</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; dbSNP:rs1250662891." id="VAR_070345" evidence="22">
<original>P</original>
<variation>R</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with autism spectrum disorder; unknown pathological significance." id="VAR_079929" evidence="19">
<original>T</original>
<variation>I</variation>
<location>
<position position="143"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; also found in a patient with benign epilepsy with centrotemporal spike; dbSNP:rs587780353." id="VAR_067726" evidence="18 22">
<original>F</original>
<variation>I</variation>
<location>
<position position="183"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; unknown pathological significance." id="VAR_070346" evidence="23">
<original>I</original>
<variation>S</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with schizophrenia; unknown pathological significance; dbSNP:rs1377082706." id="VAR_079930" evidence="19">
<original>T</original>
<variation>N</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; unknown pathological significance." id="VAR_070347" evidence="22">
<original>C</original>
<variation>Y</variation>
<location>
<position position="231"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; results in reduced high-affinity zinc mediated inhibition." id="VAR_070348" evidence="22">
<original>A</original>
<variation>V</variation>
<location>
<position position="243"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs868215122." id="VAR_067727" evidence="18">
<original>D</original>
<variation>N</variation>
<location>
<position position="252"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_010938" evidence="36">
<original>K</original>
<variation>E</variation>
<location>
<position position="270"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs148531310." id="VAR_067728" evidence="18">
<original>S</original>
<variation>F</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; dbSNP:rs199528312." id="VAR_070349" evidence="22">
<original>A</original>
<variation>V</variation>
<location>
<position position="290"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; unknown pathological significance; dbSNP:rs568484876." id="VAR_070350" evidence="23">
<original>G</original>
<variation>S</variation>
<location>
<position position="295"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs148511104." id="VAR_079931" evidence="19">
<original>P</original>
<variation>S</variation>
<location>
<position position="336"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample." id="VAR_071624" evidence="24">
<original>S</original>
<variation>F</variation>
<location>
<position position="349"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; dbSNP:rs761168789." id="VAR_070351" evidence="22">
<original>R</original>
<variation>W</variation>
<location>
<position position="370"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs149344082." id="VAR_067729" evidence="18">
<original>E</original>
<variation>K</variation>
<location>
<position position="371"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation." id="VAR_067730" evidence="18">
<original>E</original>
<variation>K</variation>
<location>
<position position="373"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with neonatal onset epileptic encephalopathy; unknown pathological significance; dbSNP:rs1057519551." id="VAR_078109" evidence="31">
<original>N</original>
<variation>D</variation>
<location>
<position position="380"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased protein abundance; loss of localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by increased glutamate potency and decreased glycine potency; dbSNP:rs1555496111." id="VAR_070352" evidence="22 30">
<original>C</original>
<variation>R</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs139033056." id="VAR_067731" evidence="18">
<original>G</original>
<variation>E</variation>
<location>
<position position="449"/>
</location>
</feature>
<feature type="sequence variant" description="No effect on localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by increased glutamate potency; dbSNP:rs145956175." id="VAR_079932" evidence="19 30">
<original>V</original>
<variation>M</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation." id="VAR_067732" evidence="18">
<original>F</original>
<variation>S</variation>
<location>
<position position="459"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased protein abundance; decreased localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency." id="VAR_070353" evidence="23 30">
<original>G</original>
<variation>R</variation>
<location>
<position position="483"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased protein abundance; decreased localization to the cell membrane; no significant effect on calcium ion transmembrane import into cytosol; dbSNP:rs1360906241." id="VAR_070354" evidence="23 30">
<original>R</original>
<variation>W</variation>
<location>
<position position="504"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; no effect on localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by increased glutamate potency; dbSNP:rs796052543." id="VAR_079933" evidence="30">
<original>V</original>
<variation>A</variation>
<location>
<position position="506"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased protein abundance; decreased localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by affected receptor kinetics; dbSNP:rs397518470." id="VAR_070355" evidence="23 30">
<original>R</original>
<variation>H</variation>
<location>
<position position="518"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased protein abundance; decreased localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by affected receptor kinetics; dbSNP:rs397518468." id="VAR_070356" evidence="21 30">
<original>T</original>
<variation>M</variation>
<location>
<position position="531"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD." id="VAR_070357" evidence="22">
<location>
<position position="547"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; no effect on localization to the cell membrane; loss of glutamate-gated calcium ion channel activity." id="VAR_070358" evidence="23 32">
<original>A</original>
<variation>T</variation>
<location>
<position position="548"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; no effect on localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by increased glutamate and glycine potency with delay in rise time and slower deactivation time course; dbSNP:rs397518450." id="VAR_069382" evidence="20 32">
<original>P</original>
<variation>R</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_079934" evidence="19">
<original>F</original>
<variation>S</variation>
<location>
<position position="576"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs551688681." id="VAR_067733" evidence="18">
<original>H</original>
<variation>R</variation>
<location>
<position position="595"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation." id="VAR_067734" evidence="18">
<original>S</original>
<variation>F</variation>
<location>
<position position="598"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; the mutant receptor has decreased calcium permeability; shows a dominant-negative effect; dbSNP:rs397518447." id="VAR_065899" evidence="17">
<original>N</original>
<variation>K</variation>
<location>
<position position="615"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; dbSNP:rs397514557." id="VAR_069383" evidence="20">
<original>L</original>
<variation>V</variation>
<location>
<position position="649"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; affects receptor kinetics; dbSNP:rs397518471." id="VAR_070359" evidence="23">
<original>F</original>
<variation>V</variation>
<location>
<position position="652"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation." id="VAR_067735" evidence="18">
<original>M</original>
<variation>I</variation>
<location>
<position position="653"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; no effect on localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by increased glutamate and glycine potency." id="VAR_070360" evidence="23 30">
<original>K</original>
<variation>N</variation>
<location>
<position position="669"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased protein abundance; decreased localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency; dbSNP:rs796052548." id="VAR_079935" evidence="30">
<original>V</original>
<variation>G</variation>
<location>
<position position="685"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased protein abundance; decreased localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency and decreased open probability." id="VAR_070361" evidence="23 30">
<original>I</original>
<variation>T</variation>
<location>
<position position="694"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; no effect on localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by increased glutamate potency and decreased open probability; dbSNP:rs1555491648." id="VAR_070362" evidence="22 30">
<original>P</original>
<variation>S</variation>
<location>
<position position="699"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency and decreased open probability." id="VAR_070363" evidence="22 30">
<original>M</original>
<variation>V</variation>
<location>
<position position="705"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs143031592." id="VAR_067736" evidence="18">
<original>G</original>
<variation>E</variation>
<location>
<position position="712"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased protein abundance; no effect on localization to the cell membrane; no significant effect on calcium ion transmembrane import into cytosol." id="VAR_070364" evidence="22 30">
<original>E</original>
<variation>K</variation>
<location>
<position position="714"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; unknown pathological significance; dbSNP:rs1057519552." id="VAR_078110" evidence="31">
<original>A</original>
<variation>D</variation>
<location>
<position position="716"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased protein abundance; decreased localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency; dbSNP:rs762659685." id="VAR_070365" evidence="23 30">
<original>A</original>
<variation>T</variation>
<location>
<position position="716"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased protein abundance; decreased localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency and decreased open probability; dbSNP:rs1555488144." id="VAR_070366" evidence="22 30">
<original>A</original>
<variation>T</variation>
<location>
<position position="727"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased protein abundance; decreased localization to the cell membrane; decreased glutamate-gated calcium ion channel activity characterized by drastically decreased glutamate agonist potency, decreased glycine agonist potency, reduced amplitude of current response, shortened synaptic-like response time course, decreased channel open probability and enhanced sensitivity to negative allosteric modulators; dbSNP:rs796052549." id="VAR_070367" evidence="23 30 35">
<original>D</original>
<variation>N</variation>
<location>
<position position="731"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; no effect on localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency." id="VAR_070368" evidence="22 30">
<original>V</original>
<variation>L</variation>
<location>
<position position="734"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation." id="VAR_067737" evidence="18">
<original>G</original>
<variation>W</variation>
<location>
<position position="740"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample." id="VAR_071625" evidence="24">
<original>G</original>
<variation>A</variation>
<location>
<position position="762"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; decreased protein abundance; decreased localization to the cell membrane; changed glutamate-gated calcium ion channel activity characterized by decreased glutamate potency and decreased open probability." id="VAR_070369" evidence="22 30">
<original>K</original>
<variation>E</variation>
<location>
<position position="772"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; increase in receptor response to agonists; decrease in the actions of endogenous negative modulators; increase in channel open probability; prolonged deactivation time course." id="VAR_072750" evidence="25">
<original>L</original>
<variation>M</variation>
<location>
<position position="812"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; unknown pathological significance; dbSNP:rs780654733." id="VAR_070370" evidence="22">
<original>I</original>
<variation>T</variation>
<location>
<position position="814"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; gain-of-function characterized by enhanced agonist potency, reduced sensitivity to endogenous negative inhibitors, prolonged synaptic-like response time course, increased single-channel mean open time and increased channel open probability; dbSNP:rs796052551." id="VAR_071626" evidence="26 34">
<original>M</original>
<variation>V</variation>
<location>
<position position="817"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs150316865." id="VAR_079936" evidence="19">
<original>V</original>
<variation>M</variation>
<location>
<position position="852"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with autism; unknown pathological significance; dbSNP:rs777684328." id="VAR_078690" evidence="27">
<original>D</original>
<variation>N</variation>
<location>
<position position="884"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation." id="VAR_067738" evidence="18 24">
<original>G</original>
<variation>E</variation>
<location>
<position position="889"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; dbSNP:rs1555482933." id="VAR_070371" evidence="22">
<original>I</original>
<variation>F</variation>
<location>
<position position="904"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation." id="VAR_067739" evidence="18">
<original>R</original>
<variation>K</variation>
<location>
<position position="920"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs200037904." id="VAR_079937" evidence="19">
<original>A</original>
<variation>V</variation>
<location>
<position position="922"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs767268773." id="VAR_067740" evidence="18">
<original>S</original>
<variation>F</variation>
<location>
<position position="929"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; unknown pathological significance; dbSNP:rs933322445." id="VAR_070372" evidence="23">
<original>D</original>
<variation>N</variation>
<location>
<position position="933"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs769602505." id="VAR_079938" evidence="19">
<original>D</original>
<variation>N</variation>
<location>
<position position="937"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs765370528." id="VAR_067741" evidence="18">
<original>E</original>
<variation>K</variation>
<location>
<position position="962"/>
</location>
</feature>
<feature type="sequence variant" description="Probable disease-associated variant found in a patient with schizophrenia." id="VAR_079939" evidence="19">
<original>A</original>
<variation>T</variation>
<location>
<position position="968"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD; dbSNP:rs886039239." id="VAR_070373" evidence="22">
<original>N</original>
<variation>S</variation>
<location>
<position position="976"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with neonatal onset epileptic encephalopathy; unknown pathological significance; dbSNP:rs531782747." id="VAR_078111" evidence="31">
<original>N</original>
<variation>S</variation>
<location>
<position position="989"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with schizophrenia; unknown pathological significance; dbSNP:rs1258974659." id="VAR_079940" evidence="19">
<original>V</original>
<variation>M</variation>
<location>
<position position="998"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs138809301." id="VAR_079941" evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="1064"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation." id="VAR_067742" evidence="18">
<original>E</original>
<variation>K</variation>
<location>
<position position="1073"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs867432846." id="VAR_067743" evidence="18">
<original>P</original>
<variation>L</variation>
<location>
<position position="1074"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample." id="VAR_071627" evidence="24">
<original>P</original>
<variation>L</variation>
<location>
<position position="1132"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample." id="VAR_071628" evidence="24">
<original>P</original>
<variation>S</variation>
<location>
<position position="1133"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs267604687." id="VAR_067744" evidence="18">
<original>D</original>
<variation>N</variation>
<location>
<position position="1153"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs867464241." id="VAR_067745" evidence="18">
<original>E</original>
<variation>K</variation>
<location>
<position position="1175"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with schizophrenia; unknown pathological significance; dbSNP:rs747136651." id="VAR_079942" evidence="19">
<original>T</original>
<variation>S</variation>
<location>
<position position="1229"/>
</location>
</feature>
<feature type="sequence variant" description="In FESD." id="VAR_070374" evidence="23">
<original>D</original>
<variation>N</variation>
<location>
<position position="1251"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with continuous spike-wave discharges during slow-wave sleep; also found in a patient with drug-resistant focal epilepsy; also found in a cutaneous malignant melanoma sample as somatic mutation; unknown pathological significance; dbSNP:rs145063086." id="VAR_067746" evidence="18 19 23 31">
<original>A</original>
<variation>G</variation>
<location>
<position position="1276"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs367543132." id="VAR_067747" evidence="18">
<original>R</original>
<variation>K</variation>
<location>
<position position="1285"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs774419037." id="VAR_067748" evidence="18">
<original>R</original>
<variation>W</variation>
<location>
<position position="1318"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation." id="VAR_067749" evidence="18">
<original>P</original>
<variation>L</variation>
<location>
<position position="1366"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation." id="VAR_067750" evidence="18">
<original>D</original>
<variation>N</variation>
<location>
<position position="1421"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs976259560." id="VAR_067751" evidence="18">
<original>S</original>
<variation>L</variation>
<location>
<position position="1425"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation; dbSNP:rs138415164." id="VAR_067752" evidence="18">
<original>E</original>
<variation>K</variation>
<location>
<position position="1426"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a cutaneous malignant melanoma sample; somatic mutation." id="VAR_067753" evidence="18">
<original>S</original>
<variation>C</variation>
<location>
<position position="1462"/>
</location>
</feature>
<feature type="mutagenesis site" description="Changed glutamate-gated calcium ion channel activity characterized by increased desensitization." evidence="32">
<original>P</original>
<variation>A</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="mutagenesis site" description="Changed glutamate-gated calcium ion channel activity characterized by accelerated response activation time and increased desensitization." evidence="32">
<original>P</original>
<variation>G</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="mutagenesis site" description="Changed glutamate-gated calcium ion channel activity characterized by increased desensitization." evidence="32">
<original>P</original>
<variation>I</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="mutagenesis site" description="Changed glutamate-gated calcium ion channel activity characterized by increased glutamate and glycine potency with delay in rise time and slower deactivation time course." evidence="32">
<original>P</original>
<variation>K</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on localization to the cell membrane. Changed glutamate-gated calcium ion channel activity characterized by increased desensitization." evidence="32">
<original>P</original>
<variation>L</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on localization to the cell membrane. Changed glutamate-gated calcium ion channel activity characterized by decreased response amplitude and changed desensitization without effect on response rise time or deactivation time course." evidence="32">
<original>P</original>
<variation>Q</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="405"/>
<end position="410"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="414"/>
<end position="416"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="417"/>
<end position="421"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="424"/>
<end position="426"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="434"/>
<end position="442"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="449"/>
<end position="458"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="459"/>
<end position="471"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="474"/>
<end position="479"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="482"/>
<end position="485"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="487"/>
<end position="489"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="492"/>
<end position="494"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="495"/>
<end position="501"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="506"/>
<end position="508"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="516"/>
<end position="519"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="522"/>
<end position="524"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="528"/>
<end position="538"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="668"/>
<end position="671"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="673"/>
<end position="675"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="676"/>
<end position="678"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="686"/>
<end position="688"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="689"/>
<end position="697"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="699"/>
<end position="705"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="706"/>
<end position="708"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="713"/>
<end position="721"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="726"/>
<end position="731"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="732"/>
<end position="740"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="743"/>
<end position="745"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="747"/>
<end position="750"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="751"/>
<end position="753"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="756"/>
<end position="761"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="764"/>
<end position="766"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="772"/>
<end position="784"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="787"/>
<end position="795"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1461"/>
<end position="1464"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3NFL"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5H8F"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5H8H"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5H8N"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5H8Q"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5I2K"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5I2N"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5KCJ"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5KDT"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5TP9"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5TPA"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250"/>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="B7ZSK1"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P35436"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q00959"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255"/>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20890276"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21499247"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22833210"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23033978"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23933818"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23933819"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23933820"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24455489"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24504326"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24903190"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26637798"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26875626"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26919761"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27839871"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27864847"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28095420"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28105280"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28126851"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28182669"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8061049"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8768735"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8061049"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8768735"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000305"/>
<sequence length="1464" mass="165283" checksum="AF5EDD599EC0B1E3" modified="1996-11-01" version="1" precursor="true">MGRVGYWTLLVLPALLVWRGPAPSAAAEKGPPALNIAVMLGHSHDVTERELRTLWGPEQAAGLPLDVNVVALLMNRTDPKSLITHVCDLMSGARIHGLVFGDDTDQEAVAQMLDFISSHTFVPILGIHGGASMIMADKDPTSTFFQFGASIQQQATVMLKIMQDYDWHVFSLVTTIFPGYREFISFVKTTVDNSFVGWDMQNVITLDTSFEDAKTQVQLKKIHSSVILLYCSKDEAVLILSEARSLGLTGYDFFWIVPSLVSGNTELIPKEFPSGLISVSYDDWDYSLEARVRDGIGILTTAASSMLEKFSYIPEAKASCYGQMERPEVPMHTLHPFMVNVTWDGKDLSFTEEGYQVHPRLVVIVLNKDREWEKVGKWENHTLSLRHAVWPRYKSFSDCEPDDNHLSIVTLEEAPFVIVEDIDPLTETCVRNTVPCRKFVKINNSTNEGMNVKKCCKGFCIDILKKLSRTVKFTYDLYLVTNGKHGKKVNNVWNGMIGEVVYQRAVMAVGSLTINEERSEVVDFSVPFVETGISVMVSRSNGTVSPSAFLEPFSASVWVMMFVMLLIVSAIAVFVFEYFSPVGYNRNLAKGKAPHGPSFTIGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEFVDQVTGLSDKKFQRPHDYSPPFRFGTVPNGSTERNIRNNYPYMHQYMTKFNQKGVEDALVSLKTGKLDAFIYDAAVLNYKAGRDEGCKLVTIGSGYIFATTGYGIALQKGSPWKRQIDLALLQFVGDGEMEELETLWLTGICHNEKNEVMSSQLDIDNMAGVFYMLAAAMALSLITFIWEHLFYWKLRFCFTGVCSDRPGLLFSISRGIYSCIHGVHIEEKKKSPDFNLTGSQSNMLKLLRSAKNISSMSNMNSSRMDSPKRAADFIQRGSLIMDMVSDKGNLMYSDNRSFQGKESIFGDNMNELQTFVANRQKDNLNNYVFQGQHPLTLNESNPNTVEVAVSTESKANSRPRQLWKKSVDSIRQDSLSQNPVSQRDEATAENRTHSLKSPRYLPEEMAHSDISETSNRATCHREPDNSKNHKTKDNFKRSVASKYPKDCSEVERTYLKTKSSSPRDKIYTIDGEKEPGFHLDPPQFVENVTLPENVDFPDPYQDPSENFRKGDSTLPMNRNPLHNEEGLSNNDQYKLYSKHFTLKDKGSPHSETSERYRQNSTHCRSCLSNMPTYSGHFTMRSPFKCDACLRMGNLYDIDEDQMLQETGNPATGEQVYQQDWAQNNALQLQKNKLRISRQHSYDNIVDKPRELDLSRPSRSISLKDRERLLEGNFYGSLFSVPSSKLSGKKSSLFPQGLEDSKRSKSLLPDHTSDNPFLHSHRDDQRLVIGRCPSDPYKHSLPSQAVNDSYLRSSLRSTASYCSRDSRGHNDVYISEHVMPYAANKNNMYSTPRVLNSCSNRRVYKKMPSIESDV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

